Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSKIN.L Share News (SKIN)

  • There is currently no data for SKIN

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Integumen upbeat on promising cannabis skincare test results

Mon, 25th Mar 2019 11:39

(Sharecast News) - Integumen announced positive results from further tests in formulations on Monday, all of which contained low-concentrations of hemp-derived cannabinoid (CBD) oils.The AIM-traded firm said the formulations increased production of pro-collagen, and indicated a reduction of inflammation on 'Labskin', leading to a soothing effect on irritated and sore skin.It explained that pro-collagen had been shown to improve the "youthfulness" of skin appearance, and was a precursor of collagen - the protein that adds strength and support to body tissue.The amount of pro-collagen production could be directly measured, as no additional collagen was added to the Labskin model.Inflammation, meanwhile, could be caused by a variety of reasons ranging from bacterial infection to irritation from harsh skin products, Integumen explained.It said Labskin was capable of releasing chemical markers that indicated inflammation damage occurring on the skin test model.The trial data showed that formulations containing hemp-derived CBD oil, in low concentrations, reduced the release of those inflammation markers, indicating a soothing effect on sore skin.Ingegume's updates on 7 January and 20 February noted that Cellulac, which is 9.35% owned by Integumen, had developed a low-cost hemp-derived CBD oil extraction process and was collaborating with Labskin to provide a formulation for the 'STOER For Men' range of cosmetics."Scientific evidence to back up anti-ageing or problematic skin treatments is far superior to anecdotal percentages of product testers," said Integumen chief executive officer Gerard Brandon."With no animal testing allowed, consumers still have a right to know what the real impact and effect of products have on their skin, before they use it."Further tests and product approvals were still required before consideration of launching an extension to the range of STOER For Men skin care products, Brandon explained."Labskin is now offering the same test services to clients adding CBD to their skin-care and cosmetic range of products."
More News
24 Jul 2019 16:09

UK Shareholder Meetings Calendar - Next 7 Days

Thursday 25 JulyPennon GroupRecordVPImmunodiagnostics Systems & La 26 European by

Read more
12 Jul 2019 11:57

Open Orphan Divests Remaining 3.1% Stake In Integumen

(Alliance News) - Open Orphan PLC has netted over GBP500,000 after selling the rest of its shares in skin-care firm Integumen PLC, Open Orphan said on Friday.The sale of the 30.1 million on

Read more
27 Jun 2019 10:52

Integumen Expects Continued Growth In Year Ahead As 2018 Loss Narrows

(Alliance News) - Integumen PLC on Thursday expressed confidence for the year ahead after reporting a sharply narrowed loss in 2018.The Omega-3 and cannabidiol oil supplier said its pretax

Read more
21 May 2019 11:31

Integumen Continues Strong Growth Momentum Into 2019; Chair Resigns

LONDON (Alliance News) - Integumen PLC said Tuesday it continued its strong growth momentum into 2019 after 2018 performed ahead of expectations.Meanwhile, it appointed a new chair the of a

Read more
21 May 2019 11:04

Integumen narrows losses as Labskin products begin full skin-care test services

(Sharecast News) - Life sciences company Integumen narrowed losses in its last trading year thanks to a significant increase in revenues.

Read more
10 May 2019 12:37

Integumen Rolls-Out Labskin Human Clone Skin Testing Platform

LONDON (Alliance News) - Integumen PLC on Friday said it has launched the Labskin human clone skin testing platform into the medical device and clinical research sectors.Labskin allows and

Read more
12 Apr 2019 10:46

WINNERS & LOSERS SUMMARY: Spread Betting Firms Fall After Plus500 Woe

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Friday.----------FTSE 100 - LOSERS----------Micro Focus

Read more
12 Apr 2019 10:13

Integumen Raises Cash To Cut Debt And Acquire RinoCloud (ALLISS)

LONDON (Alliance News) - Integumen PLC on Friday said it has agreed to buy scientific data management company RinoCloud Ltd for GBP3.0 million, funded through a share issue.Integumen will a

Read more
12 Apr 2019 08:46

Integumen acquires data management service RinoCloud

(Sharecast News) - Life sciences outfit Integumen agreed to acquire data management firm RinoCloud for a total of £3m on Friday as part of its efforts to build out its Labskin AI platform.

Read more
5 Mar 2019 11:44

Integumen Buys Cellulac's Laboratory Test Equipment For GBP400,000

LONDON (Alliance News) - Integumen PLC on Tuesday said it has entered into an agreement with Cellulac Ltd to acquire hi-tech laboratory test equipment, to be installed into the enlarged Labskin UK

Read more
20 Feb 2019 10:27

WINNERS & LOSERS SUMMARY: Sainsbury's Sinks As CMA Thwarts Asda Merger

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Wednesday.----------FTSE 100 - WINNERS----------John up

Read more
8 Feb 2019 08:27

Integumen shoots up on Labskin AI rollout

(Sharecast News) - Integumen leapt on Friday as it announced the roll-out of its Labskin AI product, a cloud-based digital life science, automation management tool.

Read more
7 Jan 2019 09:31

Integumen revenues soar as Labskin sales take off

(Sharecast News) - Integumen saw revenues more than triple in its last trading year following a major restructuring project over at its Innovenn subsidiary.

Read more
13 Dec 2018 15:40

Integumen teams up with Rinocloud to develop 'Labskin-on-a-Chip'

(Sharecast News) - Integumen announced a cross-platform biophysics agreement with artificial intelligence (AI) developer Rinocloud on Thursday, in association with Cork Institute of Technology's Nimbus embedded systems research institute and its Cappa Photonics Laboratory, to develop 'Labskin-On-A-Chip' (LOAC) technology.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.